2p2h: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "2p2h" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2p2h.png|left|200px]] | [[Image:2p2h.png|left|200px]] | ||
{{STRUCTURE_2p2h| PDB=2p2h | SCENE= }} | {{STRUCTURE_2p2h| PDB=2p2h | SCENE= }} | ||
===Crystal structure of the VEGFR2 kinase domain in complex with a pyridinyl-triazine inhibitor=== | ===Crystal structure of the VEGFR2 kinase domain in complex with a pyridinyl-triazine inhibitor=== | ||
{{ABSTRACT_PUBMED_17253678}} | {{ABSTRACT_PUBMED_17253678}} | ||
Revision as of 19:45, 25 July 2012
Crystal structure of the VEGFR2 kinase domain in complex with a pyridinyl-triazine inhibitor
Template:ABSTRACT PUBMED 17253678
About this Structure
2p2h is a 1 chain structure of Vascular Endothelial Growth Factor Receptor with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Hodous BL, Geuns-Meyer SD, Hughes PE, Albrecht BK, Bellon S, Bready J, Caenepeel S, Cee VJ, Chaffee SC, Coxon A, Emery M, Fretland J, Gallant P, Gu Y, Hoffman D, Johnson RE, Kendall R, Kim JL, Long AM, Morrison M, Olivieri PR, Patel VF, Polverino A, Rose P, Tempest P, Wang L, Whittington DA, Zhao H. Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine Tie-2 kinase inhibitor. J Med Chem. 2007 Feb 22;50(4):611-26. Epub 2007 Jan 25. PMID:17253678 doi:10.1021/jm061107l